Pure Global AI
NCT06308289Recruiting

Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique in COPD

Combined Effects of Global Posture Re-education and Active Cycle of Breathing Technique on Cardiorespiratory Fitness, Posture and Quality of Life in Chronic Obstructive Pulmonary Disease
Riphah International UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Chronic Obstructive Pulmonary Disease
Drug/Device/Intervention
Global Posture Re-education
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Riphah International University
Location
Gujranwala, Pakistan
Timeline & enrollment
Phase
N/A
Start date
Mar 03, 2024
End date
Jun 15, 2024
Enrollment
68 participants
Primary outcome

SF- 36 Questionnaire,FEV1/FVC ratio,6-minute walk test,Photogrammetry,Forced expiratory volume (FEV1),Forced vital capacity (FVC)

Summary

The randomized controlled trial will involve 30 participants, with Group A receiving GPRM and
 ACBT, while Group B follows the conventional COPD model that includes ACBT only.Assessments
 of heart rate, physical fitness, and quality of life will contribute to a nuanced
 understanding of joint function, informing future COPD treatment paradigms.

ICD-10 classifications
Other chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease, unspecifiedOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedChronic obstructive pulmonary disease with acute lower respiratory infection
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06308289
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06308289 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Recruiting. The study focuses on Chronic Obstructive Pulmonary Disease. Target enrollment is 68 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.